293 Mirvetuximab soravtansine, the first FR-targeting antibodydrug conjugate (ADC), achieves OS benefits in platinum-resistant ovarian cancer
Schedule your FREE consultation with us today by calling (972) 294-6992.
By the time evening arrives, the most intense "energy-boosting" effects have leveled off, allowing the body to naturally transition into sleep mode
Journal of peptide science: an official publication of the European Peptide Society, 27 (9), e3337
hard to find at this quality
ScGrx7 is particularly suited for unbiased kinetic and mechanistic studies because of its high activity, the absence of ironsulfur clusters in enzyme preparations and the lack of additional cysteine residues 11 (glutaredoxins with two or more cysteine residues have complex kinetics because of alternative redox states and reactions 10,12,14,17,30,31,32,33 )